University research records

Universidade da Coruña

5 imported, source-linked research records. All imported publication dates.

All imported publication dates

5 matching research records

Topic: Canagliflozin and SGLT2. Only records linked to Universidade da Coruña are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.

Back to university profile →

Showing 1–5 of 5 matching records. Counts update as records arrive.

  1. Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients

    December 24, 2025 · 2 citations

    Open original record →

  2. Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients.

    November 21, 2025 · 0 citations · Open access

    Open original record →

  3. HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study

    November 3, 2025 · 10 citations · Open access

    Open original record →

  4. Characteristics and treatment of patients with heart failure followed in heart failure units in Spain. Differences according to the type of unit

    November 1, 2025 · 0 citations

    Open original record →

  5. The sGC activator runcaciguat is associated with a strong reduction in albuminuria and good tolerability in CKD patients with or without an SGLT2 inhibitor. Results of the CONCORD study

    April 26, 2024 · 2 citations · Open access

    Open original record →